- Home
- CRNX vs ELP Comparison
CRNX vs ELP Comparison
Compare CRNX & ELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- ELP
- Stock Information
- Founded
- CRNX 2008
- ELP 1954
- Country
- CRNX United States
- ELP Brazil
- Employees
- CRNX N/A
- ELP N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- ELP Electric Utilities: Central
- Sector
- CRNX Health Care
- ELP Utilities
- Exchange
- CRNX Nasdaq
- ELP Nasdaq
- Market Cap
- CRNX 5.2B
- ELP 5.5B
- IPO Year
- CRNX 2018
- ELP 1997
- Fundamental
- Price
- CRNX $54.66
- ELP $5.93
- Analyst Decision
- CRNX Strong Buy
- ELP
- Analyst Count
- CRNX 10
- ELP 0
- Target Price
- CRNX $74.40
- ELP N/A
- AVG Volume (30 Days)
- CRNX 594.1K
- ELP 321.3K
- Earning Date
- CRNX 11-12-2024
- ELP 11-06-2024
- Dividend Yield
- CRNX N/A
- ELP 4.14%
- EPS Growth
- CRNX N/A
- ELP 43.89
- EPS
- CRNX N/A
- ELP 0.19
- Revenue
- CRNX $1,038,999.00
- ELP $4,076,906,276.00
- Revenue This Year
- CRNX N/A
- ELP N/A
- Revenue Next Year
- CRNX $195.21
- ELP $8.16
- P/E Ratio
- CRNX N/A
- ELP $7.48
- Revenue Growth
- CRNX N/A
- ELP 4.83
- 52 Week Low
- CRNX $33.67
- ELP $5.93
- 52 Week High
- CRNX $62.53
- ELP $10.64
- Technical
- Relative Strength Index (RSI)
- CRNX 45.55
- ELP 37.27
- Support Level
- CRNX $52.85
- ELP $5.93
- Resistance Level
- CRNX $56.15
- ELP $6.15
- Average True Range (ATR)
- CRNX 2.36
- ELP 0.15
- MACD
- CRNX -0.32
- ELP -0.03
- Stochastic Oscillator
- CRNX 29.91
- ELP 8.45
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
About ELP Companhia Paranaense de Energia (COPEL) (each representing one Unit consisting one Common Share and four non-voting Class B Preferred Shares)
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Holding and Services. Majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.